SNBR Fundamental Analysis - SLEEP NUMBER CORP

Fundamental Rating

SNBR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. SNBR may be in some trouble as it scores bad on both profitability and health. SNBR has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year SNBR has reported negative net income.

In the past year SNBR had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: SNBR reported negative net income in multiple years.

Of the past 5 years SNBR 4 years had a positive operating cash flow.

1.2 Ratios

SNBR has a Return On Assets of -5.15%. This is in the lower half of the industry: SNBR underperforms 67.77% of its industry peers.

The Return On Invested Capital of SNBR (4.90%) is comparable to the rest of the industry.

SNBR had an Average Return On Invested Capital over the past 3 years of 7.69%. This is below the industry average of 12.11%.

		Industry Rank	Sector Rank
ROA	-5.15%
ROE	N/A
ROIC	4.9%

ROA(3y)-0.04%

ROA(5y)6.8%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)7.69%

ROIC(5y)19.87%

1.3 Margins

Looking at the Operating Margin, with a value of 1.89%, SNBR is in line with its industry, outperforming 49.59% of the companies in the same industry.

In the last couple of years the Operating Margin of SNBR has declined.

SNBR has a Gross Margin of 60.30%. This is amongst the best in the industry. SNBR outperforms 90.08% of its industry peers.

In the last couple of years the Gross Margin of SNBR has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	1.89%
PM (TTM)	N/A
GM	60.3%

OM growth 3Y-34.99%

OM growth 5Y-18.09%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.42%

GM growth 5Y-0.76%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SNBR is destroying value.

Compared to 1 year ago, SNBR has more shares outstanding

The number of shares outstanding for SNBR has been reduced compared to 5 years ago.

Compared to 1 year ago, SNBR has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.13, we must say that SNBR is in the distress zone and has some risk of bankruptcy.

SNBR has a worse Altman-Z score (0.13) than 79.34% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	0.13

ROIC/WACC0.54

WACC9.02%

2.3 Liquidity

A Current Ratio of 0.19 indicates that SNBR may have some problems paying its short term obligations.

SNBR has a worse Current ratio (0.19) than 98.35% of its industry peers.

SNBR has a Quick Ratio of 0.19. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.

SNBR's Quick ratio of 0.08 is on the low side compared to the rest of the industry. SNBR is outperformed by 97.52% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.19
Quick Ratio	0.08

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SNBR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.82%.

SNBR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.39%.

The Revenue has been decreasing by -0.19% on average over the past years.

EPS 1Y (TTM)-2.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-395.45%

Revenue 1Y (TTM)-14.39%

Revenue growth 3Y-8.34%

Revenue growth 5Y-0.19%

Sales Q2Q%-19.71%

3.2 Future

Based on estimates for the next years, SNBR will show a very strong growth in Earnings Per Share. The EPS will grow by 34.93% on average per year.

The Revenue is expected to decrease by -2.66% on average over the next years.

EPS Next Y-2.85%

EPS Next 2Y58.79%

EPS Next 3Y43.18%

EPS Next 5Y34.93%

Revenue Next Year-14.92%

Revenue Next 2Y-7.36%

Revenue Next 3Y-3.76%

Revenue Next 5Y-2.66%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SNBR. In the last year negative earnings were reported.

Based on the Price/Forward Earnings ratio of 18.84, the valuation of SNBR can be described as rather expensive.

64.46% of the companies in the same industry are more expensive than SNBR, based on the Price/Forward Earnings ratio.

Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, SNBR is valued at the same level.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	18.84

4.2 Price Multiples

97.52% of the companies in the same industry are more expensive than SNBR, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	2.24

4.3 Compensation for Growth

SNBR's earnings are expected to grow with 43.18% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y58.79%

EPS Next 3Y43.18%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for SNBR!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SLEEP NUMBER CORP

NASDAQ:SNBR (9/16/2025, 6:11:23 PM)

After market: 8.84 0 (0%)

8.84

-0.08 (-0.9%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)07-30 2025-07-30/bmo

Earnings (Next)10-28 2025-10-28/amc

Inst Owners79.59%

Inst Owner Change8.27%

Ins Owners6.74%

Ins Owner Change32.17%

Market Cap201.29M

Analysts48.89

Price Target7.65 (-13.46%)

Short Float %29.99%

Short Ratio7.84

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-1173.18%

Min EPS beat(2)-1452.29%

Max EPS beat(2)-894.07%

EPS beat(4)2

Avg EPS beat(4)-579.79%

Min EPS beat(4)-1452.29%

Max EPS beat(4)18.3%

EPS beat(8)3

Avg EPS beat(8)-313.28%

EPS beat(12)6

Avg EPS beat(12)-155.64%

EPS beat(16)8

Avg EPS beat(16)-113.44%

Revenue beat(2)0

Avg Revenue beat(2)-6.58%

Min Revenue beat(2)-10.05%

Max Revenue beat(2)-3.11%

Revenue beat(4)0

Avg Revenue beat(4)-6.15%

Min Revenue beat(4)-10.05%

Max Revenue beat(4)-3.11%

Revenue beat(8)1

Avg Revenue beat(8)-5.03%

Revenue beat(12)2

Avg Revenue beat(12)-4.12%

Revenue beat(16)4

Avg Revenue beat(16)-3.45%

PT rev (1m)0%

PT rev (3m)15.38%

EPS NQ rev (1m)39.66%

EPS NQ rev (3m)118.92%

EPS NY rev (1m)-137.25%

EPS NY rev (3m)-90.05%

Revenue NQ rev (1m)-3.03%

Revenue NQ rev (3m)-8.25%

Revenue NY rev (1m)-4.85%

Revenue NY rev (3m)-4.85%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	18.84
P/S	0.13
P/FCF	N/A
P/OCF	41.75
P/B	N/A
P/tB	N/A
EV/EBITDA	2.24

EPS(TTM)-1.82

EYN/A

EPS(NY)0.47

Fwd EY5.31%

FCF(TTM)-0.56

FCFYN/A

OCF(TTM)0.21

OCFY2.4%

SpS66.96

BVpS-21.11

TBVpS-24.02

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-5.15%
ROE	N/A
ROCE	-29.23%
ROIC	4.9%
ROICexc	4.91%
ROICexgc	5.73%
OM	1.89%
PM (TTM)	N/A
GM	60.3%
FCFM	N/A

ROA(3y)-0.04%

ROA(5y)6.8%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)7.69%

ROIC(5y)19.87%

ROICexc(3y)7.72%

ROICexc(5y)20.02%

ROICexgc(3y)8.92%

ROICexgc(5y)24.22%

ROCE(3y)152.05%

ROCE(5y)421.6%

ROICexcg growth 3Y-45.92%

ROICexcg growth 5Y-20.82%

ROICexc growth 3Y-44.92%

ROICexc growth 5Y-20.21%

OM growth 3Y-34.99%

OM growth 5Y-18.09%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.42%

GM growth 5Y-0.76%

F-Score5

Asset Turnover1.9

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	6.26
Cap/Depr	28.53%
Cap/Sales	1.15%
Interest Coverage	250
Cash Conversion	5.35%
Profit Quality	N/A
Current Ratio	0.19
Quick Ratio	0.08
Altman-Z	0.13

F-Score5

WACC9.02%

ROIC/WACC0.54

Cap/Depr(3y)71.87%

Cap/Depr(5y)77.97%

Cap/Sales(3y)2.57%

Cap/Sales(5y)2.58%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-2.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-395.45%

EPS Next Y-2.85%

EPS Next 2Y58.79%

EPS Next 3Y43.18%

EPS Next 5Y34.93%

Revenue 1Y (TTM)-14.39%

Revenue growth 3Y-8.34%

Revenue growth 5Y-0.19%

Sales Q2Q%-19.71%

Revenue Next Year-14.92%

Revenue Next 2Y-7.36%

Revenue Next 3Y-3.76%

Revenue Next 5Y-2.66%

EBIT growth 1Y12.68%

EBIT growth 3Y-40.41%

EBIT growth 5Y-18.25%

EBIT Next Year288.61%

EBIT Next 3Y62.73%

EBIT Next 5Y48.32%

FCF growth 1Y65.5%

FCF growth 3Y-75.01%

FCF growth 5Y-51.09%

OCF growth 1Y-81.53%

OCF growth 3Y-55.11%

OCF growth 5Y-32.18%

SLEEP NUMBER CORP (SNBR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens